Global Substance Use Disorder Treatment Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI12241926

Publication Date:

December 4, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Substance Use Disorder Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Substance Use Disorder Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Substance Use Disorder Treatment market. Substance Use Disorder Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Substance Use Disorder Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Substance Use Disorder Treatment market.
Drug addiction, also called substance use disorder, is a disease that affects a person's brain and behavior and leads to an inability to control the use of a legal or illegal drug or medication. Substances such as alcohol, marijuana and nicotine also are considered drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Substance Use Disorder Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Substance Use Disorder Treatment market. It may include historical data, market segmentation by Type (e.g., Alcohol Abuse Treatment, Nicotine Abuse Treatment), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Substance Use Disorder Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Substance Use Disorder Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Substance Use Disorder Treatment industry. This include advancements in Substance Use Disorder Treatment technology, Substance Use Disorder Treatment new entrants, Substance Use Disorder Treatment new investment, and other innovations that are shaping the future of Substance Use Disorder Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Substance Use Disorder Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Substance Use Disorder Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Substance Use Disorder Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Substance Use Disorder Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Substance Use Disorder Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Substance Use Disorder Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Substance Use Disorder Treatment market.
Market Segmentation:
Substance Use Disorder Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Alcohol Abuse Treatment
Nicotine Abuse Treatment
Drug Abuse Treatment
Segmentation by application
Hospitals
Clinics
Home Care Setting
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Substance Use Disorder Treatment Market Size 2019-2030
2.1.2 Substance Use Disorder Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Substance Use Disorder Treatment Segment by Type
2.2.1 Alcohol Abuse Treatment
2.2.2 Nicotine Abuse Treatment
2.2.3 Drug Abuse Treatment
2.3 Substance Use Disorder Treatment Market Size by Type
2.3.1 Substance Use Disorder Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Substance Use Disorder Treatment Market Size Market Share by Type (2019-2024)
2.4 Substance Use Disorder Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Home Care Setting
2.5 Substance Use Disorder Treatment Market Size by Application
2.5.1 Substance Use Disorder Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Substance Use Disorder Treatment Market Size Market Share by Application (2019-2024)
3 Substance Use Disorder Treatment Market Size by Player
3.1 Substance Use Disorder Treatment Market Size Market Share by Players
3.1.1 Global Substance Use Disorder Treatment Revenue by Players (2019-2024)
3.1.2 Global Substance Use Disorder Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Substance Use Disorder Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Substance Use Disorder Treatment by Regions
4.1 Substance Use Disorder Treatment Market Size by Regions (2019-2024)
4.2 Americas Substance Use Disorder Treatment Market Size Growth (2019-2024)
4.3 APAC Substance Use Disorder Treatment Market Size Growth (2019-2024)
4.4 Europe Substance Use Disorder Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Substance Use Disorder Treatment Market Size Growth (2019-2024)
5 Americas
5.1 Americas Substance Use Disorder Treatment Market Size by Country (2019-2024)
5.2 Americas Substance Use Disorder Treatment Market Size by Type (2019-2024)
5.3 Americas Substance Use Disorder Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Substance Use Disorder Treatment Market Size by Region (2019-2024)
6.2 APAC Substance Use Disorder Treatment Market Size by Type (2019-2024)
6.3 APAC Substance Use Disorder Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Substance Use Disorder Treatment by Country (2019-2024)
7.2 Europe Substance Use Disorder Treatment Market Size by Type (2019-2024)
7.3 Europe Substance Use Disorder Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Substance Use Disorder Treatment by Region (2019-2024)
8.2 Middle East & Africa Substance Use Disorder Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Substance Use Disorder Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Substance Use Disorder Treatment Market Forecast
10.1 Global Substance Use Disorder Treatment Forecast by Regions (2025-2030)
10.1.1 Global Substance Use Disorder Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Substance Use Disorder Treatment Forecast
10.1.3 APAC Substance Use Disorder Treatment Forecast
10.1.4 Europe Substance Use Disorder Treatment Forecast
10.1.5 Middle East & Africa Substance Use Disorder Treatment Forecast
10.2 Americas Substance Use Disorder Treatment Forecast by Country (2025-2030)
10.2.1 United States Substance Use Disorder Treatment Market Forecast
10.2.2 Canada Substance Use Disorder Treatment Market Forecast
10.2.3 Mexico Substance Use Disorder Treatment Market Forecast
10.2.4 Brazil Substance Use Disorder Treatment Market Forecast
10.3 APAC Substance Use Disorder Treatment Forecast by Region (2025-2030)
10.3.1 China Substance Use Disorder Treatment Market Forecast
10.3.2 Japan Substance Use Disorder Treatment Market Forecast
10.3.3 Korea Substance Use Disorder Treatment Market Forecast
10.3.4 Southeast Asia Substance Use Disorder Treatment Market Forecast
10.3.5 India Substance Use Disorder Treatment Market Forecast
10.3.6 Australia Substance Use Disorder Treatment Market Forecast
10.4 Europe Substance Use Disorder Treatment Forecast by Country (2025-2030)
10.4.1 Germany Substance Use Disorder Treatment Market Forecast
10.4.2 France Substance Use Disorder Treatment Market Forecast
10.4.3 UK Substance Use Disorder Treatment Market Forecast
10.4.4 Italy Substance Use Disorder Treatment Market Forecast
10.4.5 Russia Substance Use Disorder Treatment Market Forecast
10.5 Middle East & Africa Substance Use Disorder Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Substance Use Disorder Treatment Market Forecast
10.5.2 South Africa Substance Use Disorder Treatment Market Forecast
10.5.3 Israel Substance Use Disorder Treatment Market Forecast
10.5.4 Turkey Substance Use Disorder Treatment Market Forecast
10.5.5 GCC Countries Substance Use Disorder Treatment Market Forecast
10.6 Global Substance Use Disorder Treatment Forecast by Type (2025-2030)
10.7 Global Substance Use Disorder Treatment Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Indivior
11.1.1 Indivior Company Information
11.1.2 Indivior Substance Use Disorder Treatment Product Offered
11.1.3 Indivior Substance Use Disorder Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Indivior Main Business Overview
11.1.5 Indivior Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Substance Use Disorder Treatment Product Offered
11.2.3 Pfizer Substance Use Disorder Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Alkermes
11.3.1 Alkermes Company Information
11.3.2 Alkermes Substance Use Disorder Treatment Product Offered
11.3.3 Alkermes Substance Use Disorder Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Alkermes Main Business Overview
11.3.5 Alkermes Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Substance Use Disorder Treatment Product Offered
11.4.3 Novartis Substance Use Disorder Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Mylan
11.5.1 Mylan Company Information
11.5.2 Mylan Substance Use Disorder Treatment Product Offered
11.5.3 Mylan Substance Use Disorder Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Mylan Main Business Overview
11.5.5 Mylan Latest Developments
11.6 Cipla
11.6.1 Cipla Company Information
11.6.2 Cipla Substance Use Disorder Treatment Product Offered
11.6.3 Cipla Substance Use Disorder Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Cipla Main Business Overview
11.6.5 Cipla Latest Developments
11.7 Glenmark
11.7.1 Glenmark Company Information
11.7.2 Glenmark Substance Use Disorder Treatment Product Offered
11.7.3 Glenmark Substance Use Disorder Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Glenmark Main Business Overview
11.7.5 Glenmark Latest Developments
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Information
11.8.2 Dr. Reddy's Laboratories Substance Use Disorder Treatment Product Offered
11.8.3 Dr. Reddy's Laboratories Substance Use Disorder Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Dr. Reddy's Laboratories Main Business Overview
11.8.5 Dr. Reddy's Laboratories Latest Developments
11.9 Teva
11.9.1 Teva Company Information
11.9.2 Teva Substance Use Disorder Treatment Product Offered
11.9.3 Teva Substance Use Disorder Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Teva Main Business Overview
11.9.5 Teva Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂